The need of proper hospital
Waste management system is of prime importance and is an essential component to prevent spread and transmission of infections in Hospital.
So, this slide will give an overview for understanding Biomedical waste management.
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
This ppt has all the necessary information about "Bio-medical waste management". it is useful for student of medical field as well as anyone who is interested in knowing about it.
Hospital infection control programs can help healthcare organizations monitor and improve practices, identify risks and proactively establish policies to prevent the spread of infections
Biomedical waste
‘Bio-medical waste’ means any solid and/or liquid waste including its container and any intermediate product, which is generated during the diagnosis, treatment or immunization of human beings or animals or in research pertaining thereto or in the production or testing thereof.
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
This ppt has all the necessary information about "Bio-medical waste management". it is useful for student of medical field as well as anyone who is interested in knowing about it.
Hospital infection control programs can help healthcare organizations monitor and improve practices, identify risks and proactively establish policies to prevent the spread of infections
Biomedical waste
‘Bio-medical waste’ means any solid and/or liquid waste including its container and any intermediate product, which is generated during the diagnosis, treatment or immunization of human beings or animals or in research pertaining thereto or in the production or testing thereof.
The very first requirement in a hospital that it should do the sick no harm" - Florence Nightingale
Health care associated infections economic loss, prolonged hospital stay & adverse patient outcomes.
Biohazardous wastes are the most promising sections to manage in the present condition.There are many rules to be folowed in disposal,transportation and treatment of biohazardous waste.
Types and strategies for decomposing of Biohazard Waste.pptxNIBGE-College
This presentation cover all the related data about principles and practices of biosafety. Awareness on types of biosafety and how can dispose of the biological waste.
The Biomedical Waste Management of the wastes which are colour coded to Yellow, i.e., the Pharmaceutical and Medical Wastes are described along with the steps of Management here. Everything is explained along with Images and simple yet completely understandable contents.
The pictures placed in the document belongs to their respective owners. Strictly no copyright infringement intended.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
2. Learning Objectives
• Introduction.
• Definition.
• Objectives of Biomedical waste Management.
• Classification of biomedical waste.
• Categories of biomedical waste.
• Hazards associated with Biomedical waste manegement.
• Steps of biomedical waste management.
3. Introduction
• The need of proper hospital
Waste management system is of
prime importance and is an
essential component to prevent
spread and transmission of
infections in Hospital.
4. Definition of Biomedical waste Management
“Biomedical waste is any waste which is generated during the
Diagnosis, treatment or immunization, of human beings or animals in
hospitals, clinics or in research activities pertaining to production or
testing of biomedicals”.
5. Objectives of Biomedical waste Management
• To prevent the harm resulting from waste.
• To Minimize its volume.
• To Retrieve reusable materials.
• To Ensure safe economical disposal.
10. Hazards associated with Biomedical waste
Management
• Infection
• Genotoxicity and cytotoxicity
• Chemical toxicity
• Radioactivity hazards
• Physical injuries
11. Steps of Biomedical waste Management
Steps of
BMW
Segregation
of generated
waste
Collection
Storage
Transporta
tion
Treatment
Disposal
12. Segregation of generated waste
• Segregation of Biomedical waste is key note to successful Biomedical waste
Management.
• Separation of Biomedical waste according to their category and labelling waste
containers.
• Biomedical waste should not be mixed with any other waste.
13.
14.
15. Collection
• Proper protective equipment and waste transporting utility supply
such as waste bins, trolly, and wheelbarrows.
16. Storage
• Secured and adequate temporary waste storage space allocation is vital.
• Waste storage time is limited to 24-48 hours.
17. Transportation
• Proper personal protective equipment's (PPE’s), supplies and easily
cleanable sealed containers such as plastic buckets, trolleys can be
used to transport wastes from their temporary storage site to their
treatment / permanent disposal site.
19. Treatment and Disposal
• It is a process where we are going to treat waste (free of micro-
organism) before its disposal.
• Use of suitable treatment technique and proper protective devices
allocation is vital.
• Finally biomedical waste is disposed in accordance with requirements
applicable.